Trial Profile
Phase I study of Plasmid DNA Drugs for Crohn's disease
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 07 Jul 2017
Price :
$35
*
At a glance
- Drugs Plasmid DNA therapeutics Alma Bio Therapeutics (Primary)
- Indications Crohn's disease
- Focus Adverse reactions
- 07 Jul 2017 New trial record
- 26 Jun 2017 According to an Alma Bio Therapeutics media release, the company plans to initiate this trial in the second half of 2018.